Research positions at Translational Health Science and Technology Institute - salary up to Rs. 80000/month

Translational Health Science and Technology Institute (THSTI) is an autonomous Institute of the Department of Biotechnology, Ministry of Science and Technology, Govt. of India. The institute is an integral part of the interdisciplinary NCR Biotech Science Cluster located at Faridabad, and is designed as a dynamic, interactive organization with the mission to conduct innovative translational research and to develop research collaborations across disciplines and professions to translate concepts into tangible products to improve human health.

Recruitment as Pharmacist (5 posts) in 1mg | D.Pharm / B.Pharm / M.Pharm

1mg is India’s leading consumer health platform with over 3 Million downloads.
It aspires to be the trusted health partner for all Indians and its mission is to make healthcare accessible, understandable and affordable for a billion Indians. It enables consumers to learn more about their medicines and also find more cost-effective substitutes. 1mg’s doctor platform aims to revolutionize how a consumer finds the right healthcare professional for his needs. It’s recently launched diagnostics service brings transparency and price-effectiveness to lab tests. 1mg is an initiative taken in the spirit of public service with a vision to empower Indian consumers and caregivers to select the most appropriate healthcare service at the best possible price. The application is available as a web portal - 1mg.com and as mobile app across Android/ iOS/ Windows.

Post: Pharmacist - Vendor Location

Work as GM / DGM - Pharmacovigilance - IKYA

IKYA is the fastest growing HR solutions provider in India, offering world-class services to over 5000+ locations across the country—including leading MNCs and large Indian firms across industries—and helping nearly 84,000 associates enhance their careers every year.

Career for Business Development Manager - Generics in Abbott

At Abbott, we are enthusiastic, energetic and committed to doing great work every day. Our employees are passionate about helping to translate science into lasting contributions to health care and the health of people worldwide. At the heart of our organization is our “Promise for Life”—a statement that embodies our company's commitment to employees, shareholders, local communities and the people who depend on our company and products to live healthier lives. Vital to our promise is the speed in which we act, respond and deliver. As Abbott employees, we are ready to meet change and challenges head-on. As a result, we are a company that adapts quickly, and through our passion for innovation we are able to continually create a pipeline of products that help improve the length and quality of life around the world.
We are proud of our rich, more than 125-year history. We continue to be driven to advance leading-edge science and technologies, support diversity, focus on exceptional performance and earn the trust of those we serve

Post: Business Development Manager - Generics

Urgent openings for Pharmacovigilance Trainee in Bangalore - MSTRAT CONSULTANTS

As companies poise to grow they need partners that understand what competencies are needed for the future, and work with them to recruit and develop talent so as to multiply strategic impact. We believe in working with our clients to understand their business goals, and translating them into the distinctive capabilities that will enable individual and team action that turn intention and promise into reality.

Abbott announced the global launch of AlinIQ, the first in a series of new innovations that Abbott will be bringing to diagnostics customers around the world over the next few years. AlinIQ is a first-of-its-kind professional services and informatics solution that will enable labs to deliver greater overall productivity with their existing resources.

eNeura, Inc., a privately held medical technology company, announced that it has obtained an expanded CE Marking in Europe extending the label for its SpringTMS device to include migraine prevention. The label extension adds to the existing SpringTMS CE Marking for acute treatment of migraine and UK National Institute for Health and Care Excellence (NICE) guidance recommending single-pulse Transcranial Magnetic Stimulation (sTMS) for acute and preventative treatment of migraine.

AbbVie , a clinical-stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies to treat cancer and severe autoimmune diseases will collaborate to develop and commercialize ARGX-115. ARGX-115 is argenx' preclinical-stage human antibody program targeting the novel immuno-oncology target GARP, a protein believed to contribute to immuno-suppressive effects of T-cell

AbbVie and CytomX Therapeutics, Inc. announced that they have entered into a collaboration to co-develop and co-commercialize Probody™ Drug Conjugates against CD71, also known as transferrin receptor 1 (TfR1). CD71 is highly expressed in a number of solid and hematologic cancers and has attractive molecular properties for efficient delivery of cytotoxic payloads to tumor cells. Probody therapeutics are designed to take advantage of unique conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.